LCE 200 (Stalevo 200 50 mg / 200 mg / 200 mg)
Generic Name: carbidopa/entacapone/levodopa
Pill imprint LCE 200 has been identified as Stalevo 200 50 mg / 200 mg / 200 mg.
Stalevo 200 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Stalevo 200 50 mg / 200 mg / 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- carbidopa/entacapone/levodopa
- Imprint:
- LCE 200
- Strength:
- 50 mg / 200 mg / 200 mg
- Color:
- Red
- Size:
- 17.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0527
- Inactive Ingredients:
- corn starch
croscarmellose sodium
glycerin
hypromelloses
magnesium stearate
mannitol
polysorbate 80
povidone
sucrose
ferric oxide red
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00781-5669 | Sandoz Inc. |
Note: Inactive ingredients may vary.
More about Stalevo 200 (carbidopa / entacapone / levodopa)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
